Nath Bio-Genes Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Revenue surged significantly in the latest quarter, indicating strong market demand.
Profit before tax showed an impressive jump, reflecting improved operational efficiency.
Operating profit margins have stabilized, suggesting effective cost management strategies.

NEGATIVES

Net profit declined sharply in the latest quarter compared to previous periods, raising concerns.
Expenses rose disproportionately, impacting overall profitability despite revenue growth.
Decreasing earnings per share in the most recent quarter indicates potential challenges ahead.

Field	Jun 23	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue	235.28	22.57	31.74	43.04	243.88	32.19	36.87	51.97	283.70
Expenses	198.47	17.59	26.09	39.11	207.34	27.38	28.84	51.56	245.42
Operating Profit	36.81	4.98	5.65	3.93	36.53	4.81	8.04	0.41	38.28
Other Income	0.12	0.06	0.04	0.41	0.13	0.08	0.48	3.86	1.76
Interest	2.76	2.44	2.84	1.07	2.24	2.98	3.90	1.37	3.20
Depreciation	0.76	0.76	0.76	0.98	0.82	0.82	0.82	1.34	0.97
Profit Before Tax	33.40	1.85	4.58	2.29	33.60	1.09	3.79	1.57	35.88
Tax	0.22	0.35	0.77	0.61	0.25	-0.03	1.14	0.63	0.66
Net Profit	33.18	1.50	3.82	2.62	33.36	1.11	2.65	1.48	37.28
Eps in Rs	17.47	0.79	2.02	1.87	17.49	0.53	1.33	1.14	19.58